Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cellgram-ED in Erectile Dysfunction After Radical Prostatectomy
NCT04594850Phase 2Completed
- Sponsor
- Pharmicell Co., Ltd.
- Start
- Oct 2020
- Primary completion
- Jan 2026
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of Cellgram ED in erectile dysfunction (ED) (2 arms), sponsored by Pharmicell Co., Ltd. Primary endpoint: Change in Erectile Function score of the International Erectile Function Questionnaire at 6 months. Started Oct 2020; status: completed.
02
Drugs
Cellgram ED
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT04594850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04594850.